ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RZLT Rezolute Inc

3.91
-0.12 (-2.98%)
Pre Market
Last Updated: 20:05:36
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Rezolute Inc RZLT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.12 -2.98% 3.91 20:05:36
Open Price Low Price High Price Close Price Previous Close
4.03
more quote information »

Recent News

Date Time Source Heading
30/5/202422:00GLOBERezolute to Participate in the Jefferies Global Healthcare..
29/5/202404:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202404:37EDGAR2Form 8-K - Current report
22/5/202406:05GLOBERezolute Reports Positive Topline Results from Phase 2 Proof..
18/5/202406:21EDGAR2Form 8-K - Current report
16/5/202406:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/5/202406:05GLOBERezolute Reports Third Quarter Fiscal 2024 Financial Results..
23/4/202422:00GLOBEPhase 2 RIZE Study Sub-Analyses to be Presented at the 2024..
12/3/202408:03EDGAR2Form 8-K - Current report
12/3/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:30GLOBERezolute Reports Validation of the Potential Use of RZ358..
28/2/202400:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202409:00EDGAR2Form 8-K - Current report
22/2/202403:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202409:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202408:10EDGAR2Form 8-K - Current report
14/2/202408:05GLOBERezolute Reports Second Quarter Fiscal 2024 Results and..
30/1/202409:15EDGAR2Form 8-K - Current report
26/1/202404:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202404:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202404:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202404:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:00GLOBERezolute Expands Leadership Team with Appointment of Daron..
24/1/202400:00GLOBERezolute Receives Innovation Passport Designation from the..
15/12/202308:01EDGAR2Form 8-K - Current report
15/12/202300:00GLOBERezolute Initiates Phase 3 Clinical Study for RZ358 in..
14/12/202300:00GLOBERezolute Completes Enrollment of its Phase 2 Study in..
30/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
23/11/202309:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
23/11/202308:35EDGAR2Form 8-K - Current report
18/11/202300:00GLOBERezolute to Participate in BTIG’s 3rd Annual Ophthalmology..
16/11/202301:08EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202308:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:13EDGAR2Form 8-K - Current report
14/11/202308:05GLOBERezolute Reports First Quarter Fiscal 2024 Results
19/10/202307:30EDGAR2Form 8-K - Current report
17/10/202323:00GLOBERezolute Receives Priority Medicines (PRIME) Eligibility..
14/10/202307:47EDGAR2Form 8-K - Current report
14/10/202307:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/10/202323:00GLOBERezolute Announces Further Evidence of RZ358’s Efficacy in..
15/9/202306:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/9/202306:10EDGAR2Form 8-K - Current report
15/9/202306:05GLOBERezolute Reports Full Year Fiscal 2023 Results and..
06/9/202321:00GLOBERezolute to Participate in Upcoming Investor Conferences in..
07/7/202301:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202306:05GLOBERezolute to Initiate a Pivotal Phase 3 Study of RZ358 in..